TEN YEARS' EXPERIENCE OF STEROID ASSAYS IN THE MANAGEMENT OF BREAST CANCER

[1]  P. Schurr,et al.  Urinary steroids in the prediction of response to adrenalectomy or hypophysectomy. A second clinical trial. , 1968, Lancet.

[2]  B. Thomas,et al.  Chloromethyldimethylsilyl ethers in the routine assay of urinary 11-deoxy-17-oxosteroids by gas-liquid chromatography. , 1968, The Journal of endocrinology.

[3]  N. Sakauchi,et al.  Urinary 17-ketosteroid excretion of women with advanced breast cancer. , 1968, The Journal of clinical endocrinology and metabolism.

[4]  N. Berlin.  Clinical Evaluation in Breast Cancer Proceedings of the 1st Imperial Cancer Research Fund Symposium held in London October 21–23, 1965. J. L. Hayward and R. D. Bulbrook (eds.). New York: Academic Press, 1966. 295 pp. $14 , 1968 .

[5]  J. Stewart,et al.  Urinary steroid values as a guide to prognosis in breast cancer. , 1968, British medical journal.

[6]  D. Ae.  Endocrine aspects of breast cancer , 1967 .

[7]  D. Crocker,et al.  Adrenal structure and function in advanced carcinoma of the breast. II. The relation of steroid excretion to adrenal morphology and the outcome of adrenalectomy, with description of a new discriminant function. , 1967, JAMA.

[8]  P. Schurr,et al.  The timing of adrenalectomy and of hypophysectomy in the treatment of advanced breast cancer. , 1966, Lancet.

[9]  J. Hayward,et al.  The value of urinary steroid estimations in the prediction of response to adrenalectomy or hypophysectomy. , 1965, Cancer research.

[10]  P. Schurr,et al.  URINARY STEROID ESTIMATIONS IN THE PREDICTION OF RESPONSE TO ADRENALECTOMY OR HYPOPHYSECTOMY. , 1964, Lancet.

[11]  C. Spicer,et al.  A comparison between the urinary steroid excretion of normal women and women with advanced breast cancer. , 1962, Lancet.

[12]  J. A. Dossett,et al.  Human and Experimental Breast Cancer , 1962 .

[13]  J. Hayward,et al.  Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone. , 1960, Lancet.

[14]  B. Ray,et al.  Hypophysectomy in the treatment of metastatic mammary cancer. , 1960, American journal of surgery.

[15]  A. G. Jessiman,et al.  Severe exacerbation of cancer of the breast after oöphorectomy and adrenalectomy: report of four cases. , 1958, The New England journal of medicine.

[16]  A. Kellie,et al.  The analysis of urinary 17-oxo steroids by gradient elution. , 1957, The Biochemical journal.

[17]  A. Forrest,et al.  URINARY STEROID PATTERNS IN BREAST CANCER , 1957 .

[18]  J. Hayward,et al.  The excretion of 17-ketosteroids in the urine of patients with generalised carcinomatosis secondary to carcinoma of the breast. , 1957, Lancet.

[19]  J. Hayward,et al.  Adrenalectomy and hypophysectomy for advanced cancer of the breast; a comparative study. , 1957, Lancet.

[20]  H J ATKINS,et al.  Adrenalectomy and hypophysectomy for advanced cancer of the breast. , 1957, Lancet.

[21]  R. D. Stubbs,et al.  Indirect analysis of corticosteroids. I. The determination of 17-hydroxycorticosteroids. , 1955, The Biochemical journal.

[22]  E. Paterson,et al.  SYNTHETIC ŒSTROGENS IN MAMMARY CANCER , 1949 .

[23]  A. Segaloff.  Hormones and breast cancer. , 1966, Recent progress in hormone research.

[24]  B. Thomas,et al.  A RAPID METHOD FOR THE ESTIMATION OF TOTAL 11-DEOXY-17-OXOSTEROIDS IN URINE. , 1964, Journal of chromatography.